Cardiorenal syndrome in patients with heart failure as a stage of the cardiorenal continuum (part 2): prognosis, prevention and treatment
Cardiorenal syndrome in patients with heart failure is a regular link in the chain of cardiorenal continuum. Physicians of various specialties may encounter patients with cardiorenal syndrome: general practitioners, cardiologists, nephrologists, resuscitators, anesthetists, cardiac surgeons, etc. Th...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
SINAPS LLC
2019-03-01
|
| Series: | Архивъ внутренней медицины |
| Subjects: | |
| Online Access: | https://www.medarhive.ru/jour/article/view/900 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849400828804202496 |
|---|---|
| author | E. V. Reznik I. G. Nikitin |
| author_facet | E. V. Reznik I. G. Nikitin |
| author_sort | E. V. Reznik |
| collection | DOAJ |
| description | Cardiorenal syndrome in patients with heart failure is a regular link in the chain of cardiorenal continuum. Physicians of various specialties may encounter patients with cardiorenal syndrome: general practitioners, cardiologists, nephrologists, resuscitators, anesthetists, cardiac surgeons, etc. The currently definition, classification, pathogenesis, diagnosis and epidemiology of cardiorenal syndrome in patients with heart failure were presented in first part of our review. In the second part, prognosis, approaches to the prevention and treatment of cardiorenal syndrome in patients with heart failure are discussed. They include the treatment of cardiovascular pathology and heart failure in accordance with current guidelines for the prevention of episodes of acute and decompensated chronic heart failure; diet; smoking cessation, alcohol, nephrotoxic substances; body weight, blood pressure and glycemia control; angiotensin converting enzyme inhibitors, angiotensin receptor antagonists or angiotensin receptors and neprilisin inhibitors (ARNI), statins; reducing of the abdominal pressure and others. It is necessary to develop and introduce new approaches to nephroprotection in patients with cardiorenal syndrome, which is possible with the joint work of a multidisciplinary team. |
| format | Article |
| id | doaj-art-50224a74f55c4e6699ae10f7772b5b3a |
| institution | Kabale University |
| issn | 2226-6704 2411-6564 |
| language | Russian |
| publishDate | 2019-03-01 |
| publisher | SINAPS LLC |
| record_format | Article |
| series | Архивъ внутренней медицины |
| spelling | doaj-art-50224a74f55c4e6699ae10f7772b5b3a2025-08-20T03:37:54ZrusSINAPS LLCАрхивъ внутренней медицины2226-67042411-65642019-03-01929310610.20514/2226-6704-2019-9-2-93-106723Cardiorenal syndrome in patients with heart failure as a stage of the cardiorenal continuum (part 2): prognosis, prevention and treatmentE. V. Reznik0I. G. Nikitin1Russian National Research Medical University n.a. N.I. PirogovRussian National Research Medical University n.a. N.I. PirogovCardiorenal syndrome in patients with heart failure is a regular link in the chain of cardiorenal continuum. Physicians of various specialties may encounter patients with cardiorenal syndrome: general practitioners, cardiologists, nephrologists, resuscitators, anesthetists, cardiac surgeons, etc. The currently definition, classification, pathogenesis, diagnosis and epidemiology of cardiorenal syndrome in patients with heart failure were presented in first part of our review. In the second part, prognosis, approaches to the prevention and treatment of cardiorenal syndrome in patients with heart failure are discussed. They include the treatment of cardiovascular pathology and heart failure in accordance with current guidelines for the prevention of episodes of acute and decompensated chronic heart failure; diet; smoking cessation, alcohol, nephrotoxic substances; body weight, blood pressure and glycemia control; angiotensin converting enzyme inhibitors, angiotensin receptor antagonists or angiotensin receptors and neprilisin inhibitors (ARNI), statins; reducing of the abdominal pressure and others. It is necessary to develop and introduce new approaches to nephroprotection in patients with cardiorenal syndrome, which is possible with the joint work of a multidisciplinary team.https://www.medarhive.ru/jour/article/view/900cardiorenal continuumcardiorenal syndromechronic heart failureacute heart failurechronic kidney diseaseacute renal damageacute kidney injuryglomerular filtration ratealbuminuriaprognosismortalitysurvivalnephroprotectionpreventiontreatmentangiotensin converting enzyme inhibitorangiotensin receptor antagonistangiotensin receptors and neprilisin inhibitor (arni) |
| spellingShingle | E. V. Reznik I. G. Nikitin Cardiorenal syndrome in patients with heart failure as a stage of the cardiorenal continuum (part 2): prognosis, prevention and treatment Архивъ внутренней медицины cardiorenal continuum cardiorenal syndrome chronic heart failure acute heart failure chronic kidney disease acute renal damage acute kidney injury glomerular filtration rate albuminuria prognosis mortality survival nephroprotection prevention treatment angiotensin converting enzyme inhibitor angiotensin receptor antagonist angiotensin receptors and neprilisin inhibitor (arni) |
| title | Cardiorenal syndrome in patients with heart failure as a stage of the cardiorenal continuum (part 2): prognosis, prevention and treatment |
| title_full | Cardiorenal syndrome in patients with heart failure as a stage of the cardiorenal continuum (part 2): prognosis, prevention and treatment |
| title_fullStr | Cardiorenal syndrome in patients with heart failure as a stage of the cardiorenal continuum (part 2): prognosis, prevention and treatment |
| title_full_unstemmed | Cardiorenal syndrome in patients with heart failure as a stage of the cardiorenal continuum (part 2): prognosis, prevention and treatment |
| title_short | Cardiorenal syndrome in patients with heart failure as a stage of the cardiorenal continuum (part 2): prognosis, prevention and treatment |
| title_sort | cardiorenal syndrome in patients with heart failure as a stage of the cardiorenal continuum part 2 prognosis prevention and treatment |
| topic | cardiorenal continuum cardiorenal syndrome chronic heart failure acute heart failure chronic kidney disease acute renal damage acute kidney injury glomerular filtration rate albuminuria prognosis mortality survival nephroprotection prevention treatment angiotensin converting enzyme inhibitor angiotensin receptor antagonist angiotensin receptors and neprilisin inhibitor (arni) |
| url | https://www.medarhive.ru/jour/article/view/900 |
| work_keys_str_mv | AT evreznik cardiorenalsyndromeinpatientswithheartfailureasastageofthecardiorenalcontinuumpart2prognosispreventionandtreatment AT ignikitin cardiorenalsyndromeinpatientswithheartfailureasastageofthecardiorenalcontinuumpart2prognosispreventionandtreatment |